CURE/Digestive Diseases Research Center, Center for Neurobiology of Stress, Digestive Diseases Division, Department of Medicine, University of California Los Angeles, Los Angeles, CA 90073, USA.
Peptides. 2012 Jun;35(2):143-8. doi: 10.1016/j.peptides.2012.03.015. Epub 2012 Mar 28.
Nesfatin-1 is an 82 amino acid N-terminal fragment of nucleobindin2 that was consistently shown to reduce dark phase food intake upon brain injection in rodents. We recently reported that nesfatin-1(1-82) injected intracerebroventricularly (icv) reduces dark phase feeding in mice. Moreover, intraperitoneal injection of mid-fragment nesfatin-1 (nesfatin-1(30-59)) mimics the food intake-reducing effects of nesfatin-1(1-82), whereas N-terminal (nesfatin-1(1-29)) and C-terminal fragments (nesfatin-1(60-82)) did not. We therefore characterized the structure-activity relationship of nesfatin-1 injected icv to influence the dark phase meal pattern in mice. Mouse nesfatin-1(1-29), nesfatin-1(30-59), nesfatin-1(60-82) or vehicle was injected icv in freely fed C57Bl/6 mice immediately before the dark phase and food intake was monitored using an automated episodic feeding monitoring system. Nesfatin-1(30-59) (0.1, 0.3, 0.9 nmol/mouse) induced a dose-related reduction of 4-h food intake by 28%, 49% and 49% respectively resulting in a 23% decreased cumulative 24-h food intake compared to vehicle at the 0.3 nmol/mouse dose (p<0.05). The peak reduction occurred during the 3rd (-96%) and 4th hour (-91%) post injection and was associated with a reduced meal frequency (0-4h: -47%) and prolonged inter-meal intervals (3.1-times) compared to vehicle (p<0.05), whereas meal size was not altered. In contrast, neither nesfatin-1(1-29) nor nesfatin-1(60-82) reduced dark phase food intake at equimolar doses although nesfatin-1(60-82) prolonged inter-meal intervals (1.7-times, p<0.05). Nesfatin-1(30-59) is the active core of nesfatin-1(1-82) to induce satiety indicated by a reduced meal number during the first 4h post injection. The delayed onset may be indicative of time required to modulate other hypothalamic and medullary networks regulating nocturnal feeding as established for nesfatin-1.
nesfatin-1 是核结合蛋白 2 的 82 个氨基酸 N 端片段,在啮齿动物脑内注射时一致显示可减少暗期食物摄入。我们最近报道,nesfatin-1(1-82)脑室内注射可减少小鼠暗期摄食。此外,腹腔内注射中间片段 nesfatin-1(nesfatin-1(30-59))模拟了 nesfatin-1(1-82)的摄食减少作用,而 N 端(nesfatin-1(1-29))和 C 端片段(nesfatin-1(60-82))则没有。因此,我们研究了 nesfatin-1 注射入脑室对影响小鼠暗期摄食模式的结构-活性关系。在自由进食的 C57Bl/6 小鼠进入暗期前立即脑室内注射小鼠 nesfatin-1(1-29)、nesfatin-1(30-59)、nesfatin-1(60-82)或载体,并使用自动发作性摄食监测系统监测食物摄入。nesfatin-1(30-59)(0.1、0.3、0.9 nmol/只)诱导 4 小时食物摄入量呈剂量依赖性减少,分别减少 28%、49%和 49%,与 0.3 nmol/只剂量时的载体相比,24 小时累积食物摄入量减少 23%(p<0.05)。峰减少发生在注射后第 3 小时(-96%)和第 4 小时(-91%),与摄食频率降低(0-4 小时:-47%)和进食间隔延长(3.1 倍)有关,而摄食量没有改变。相比之下,尽管 nesfatin-1(60-82)延长了进食间隔(1.7 倍,p<0.05),但等摩尔剂量的 nesfatin-1(1-29)和 nesfatin-1(60-82)均未减少暗期食物摄入。nesfatin-1(30-59)是 nesfatin-1(1-82)诱导饱腹感的活性核心,表现为注射后前 4 小时内摄食次数减少。延迟发作可能表明需要时间来调节其他调节夜间摄食的下丘脑和延髓网络,如 nesfatin-1 所建立的那样。